Timing of b-Blocker Reintroduction and AF After Cardiac Surgery Timing of b-Blocker Reintroduction and AF After Cardiac Surgery
Does the timing of timing of beta-blocker reintroduction after cardiac surgery impact its effectiveness on the incidence of postoperative atrial fibrillation?Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - February 13, 2020 Category: Consumer Health News Tags: Anesthesiology Journal Article Source Type: news

Medications May Lower Risk Of ‘ Broken Heart ’ After Loss Of Loved One, Study Says
In this study, researchers at the University of Sydney looked at 85 spouses or parents grieving the loss of a family member. They found that those who received low doses of a beta blocker and aspirin for the first six weeks had lower spikes in blood pressure and heart rates and improvements in the tendency to form blood clots. They also had less symptoms of anxiety and depression. (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - February 12, 2020 Category: Consumer Health News Authors: Health – CBS Boston Tags: Boston News Health Healthwatch Syndicated CBSN Boston Syndicated Local Dr. Mallika Marshall Source Type: news

Beta-Blockers, ACE Inhibitors Don ’ t Raise Anaphylaxis Risk From Cardiac Catheterization Beta-Blockers, ACE Inhibitors Don ’ t Raise Anaphylaxis Risk From Cardiac Catheterization
The risk of anaphylactic reactions from contrast media used during cardiac catheterization is not increased in patients on beta-blockers or angiotensin-converting enzyme (ACE) inhibitors, according to results from a retrospective case-control study.Reuters Health Information (Source: Medscape Radiology Headlines)
Source: Medscape Radiology Headlines - December 20, 2019 Category: Radiology Tags: Cardiology News Source Type: news

Study Casts Doubt on Use of Common Heart Failure Drugs
THURSDAY, Dec. 5, 2019 -- Millions of Americans with heart failure take one of the family of beta blocker medications to help ease the condition. But in many cases, could the meds be doing more harm than good? A new study found that taking beta... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - December 5, 2019 Category: General Medicine Source Type: news

DAPA-HF: Heart Failure Toolbox Poised to Add New Drug Family DAPA-HF: Heart Failure Toolbox Poised to Add New Drug Family
' What I don't want to see is slow uptake, once it gets the indication in nondiabetics,'said one physician. Think of SGLT2 inhibitors the same way as ACE inhibitors, beta blockers, and other HF drugs.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - November 19, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

The association between premorbid beta blocker exposure and mortality in sepsis-a systematic review
The effect of premorbid β-blocker exposure on clinical outcomes in patients with sepsis is not well characterized. We aimed to examine the association between premorbid β-blocker exposure and mortality in sepsis. This systematic review suggests that β-blocker exposure prior to sepsis is associated with reduced mortality . There was insufficient data to conduct a bona fide meta-analysis. Whether the apparent reduction in mortality may be attributed to the mitigation of catecholamine excess is unclear. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - October 30, 2019 Category: Consumer Health News Source Type: news

Beta Blocker Fails to Shorten Time to First COPD Exacerbation Beta Blocker Fails to Shorten Time to First COPD Exacerbation
A new randomized placebo-controlled trial that was halted early for safety reasons has failed to confirm observational studies suggesting that beta-blockers reduce exacerbations in moderate or severe chronic obstructive pulmonary disease (COPD).Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - October 23, 2019 Category: Intensive Care Tags: Pulmonary Medicine News Source Type: news

Safety of Non-selective b-Blockers in Decompensated Cirrhosis Safety of Non-selective b-Blockers in Decompensated Cirrhosis
Treatment with non-selective beta blockers in patients with decompensated cirrhosis and ascites remains controversial. What factors might contribute to adverse events?Alimentary Pharmacology & Therapeutics (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - October 23, 2019 Category: Consumer Health News Tags: Gastroenterology Journal Article Source Type: news

Blood Pressure Med May Improve Cognitive Impairment in Autism Blood Pressure Med May Improve Cognitive Impairment in Autism
This study suggests that using beta-blockers might be a promising approach.Medscape Medical News (Source: Medscape Psychiatry Headlines)
Source: Medscape Psychiatry Headlines - September 26, 2019 Category: Psychiatry Tags: Psychiatry News Source Type: news

STOP-CRT: Maybe Stop Some HF Meds if CRT Restores Heart Function STOP-CRT: Maybe Stop Some HF Meds if CRT Restores Heart Function
It's only one study, but some highly selected patients might improve on cardiac resynchronization therapy such that RAAS inhibitors and beta blockers are no longer indicated, a researcher says.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 23, 2019 Category: Consumer Health News Tags: Cardiology News Source Type: news

Medical News Today: Beta-blockers for anxiety: What to know
Beta-blockers are a type of medication that can treat heart conditions. Some doctors also prescribe them to ease the symptoms of anxiety. Learn more in this article. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - September 20, 2019 Category: Consumer Health News Tags: Anxiety / Stress Source Type: news

Long-Term Beta Blockers Post-CABG Questioned, Even With Low LVEF Long-Term Beta Blockers Post-CABG Questioned, Even With Low LVEF
Use of guideline-recommended meds started out high after CABG but waned over time in a registry study that, controversially, also saw no survival benefit to long-term postoperative beta blockers.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - September 12, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Indications for Beta-Blocker Prescriptions in HFpEF Indications for Beta-Blocker Prescriptions in HFpEF
Are beta-blockers being unnecessarily prescribed for older adults with heart failure with preserved ejection fraction, despite little evidence of their benefit?Journal of the American Geriatrics Society (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 23, 2019 Category: Consumer Health News Tags: Internal Medicine Journal Article Source Type: news

Gallstone sufferers may one day avoid surgery thanks to new discovery
Scientists from University Hospital Erlangen, Germany, discovered the 'established' beta-blocker metoprolol blocked the growth of gallstones in mice with the painful condition. (Source: the Mail online | Health)
Source: the Mail online | Health - August 15, 2019 Category: Consumer Health News Source Type: news

When Might Post-MI Beta-Blockers Be Safely Deprescribed? When Might Post-MI Beta-Blockers Be Safely Deprescribed?
If an older patient is ischemia-free on beta-blockers 3 years later, he or she doesn't seem to confer further protection over the next 5 years, suggests data from an admittedly older registry.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - July 17, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

Another Use for Beta Blockers? Curbing A-fib
Title: Another Use for Beta Blockers? Curbing A-fibCategory: Health NewsCreated: 6/4/2019 12:00:00 AMLast Editorial Review: 6/5/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - June 5, 2019 Category: Cardiology Source Type: news

Beta Blockers Might Fight A-Fib Too
A-fib is a common heart rhythm disorder sometimes triggered by stress and negative emotions. Beta blockers are drugs that block the effects of adrenaline and related substances. (Source: WebMD Health)
Source: WebMD Health - June 4, 2019 Category: Consumer Health News Source Type: news

Beta-Blockers May Moderate Impact of Stress on Atrial Fibrillation
TUESDAY, June 4, 2019 -- β-blockers can attenuate the impact of anger or stress on atrial fibrillation (AF), according to a study published online June 4 in HeartRhythm. Rachel Lampert, M.D., from the Yale University School of Medicine in New... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 4, 2019 Category: Pharmaceuticals Source Type: news

Another Use for Beta Blockers? Curbing A-fib
TUESDAY, June 4, 2019 -- People whose heart rhythm problems stem from stress and anger may benefit from taking beta blocker drugs, a new study suggests. Atrial fibrillation (a-fib) is a common type of heart rhythm disorder sometimes triggered by... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 4, 2019 Category: General Medicine Source Type: news

Beta blockers reduce stress-induced irregular heart rhythm
The strategy of taking beta blockers could potentially improve quality of life for many of the two million Americans with the condition. (Source: Yale Science and Health News)
Source: Yale Science and Health News - June 4, 2019 Category: Universities & Medical Training Source Type: news

Beta blockers reduce stress-induced irregular heart rhythm
(Yale University) Taking beta blockers -- medications that reduce blood pressure and treat many heart conditions -- can blunt the negative effects of stress and anger on people with a history of atrial fibrillation, or irregular heart rhythm, said Yale researchers. This strategy could potentially improve quality of life for many of the 2 million Americans with the condition, according to a new study. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - June 4, 2019 Category: International Medicine & Public Health Source Type: news

Heart Patients at Risk When Pharmacies Close
MONDAY, May 13, 2019 -- When pharmacies close, people with heart disease stop taking widely used heart medications, such as statins, beta-blockers, and oral anticoagulants, according to a study published online April 19 in JAMA Network Open. Dima M.... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - May 13, 2019 Category: Pharmaceuticals Source Type: news

Could Common Heart Meds Lower Prostate Cancer Risk?
The effect was found only with atenolol (Tenormin). Two other beta blockers -- metoprolol (Lopressor/Toprol XL) and carvedilol (Coreg) -- did not appear to provide any protection against prostate cancer. (Source: WebMD Health)
Source: WebMD Health - May 3, 2019 Category: Consumer Health News Source Type: news

Could Common Heart Meds Lower Prostate Cancer Risk?
FRIDAY, May 3, 2019 -- Good news for men: That blood pressure medication you're taking might be doing double duty, helping reduce your risk of developing prostate cancer, a new study shows. Researchers found that a beta blocker called atenolol cut... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 3, 2019 Category: General Medicine Source Type: news

Adherence to CV Meds Suffers When Pharmacies Shut Down for Good Adherence to CV Meds Suffers When Pharmacies Shut Down for Good
Patients fall behind on their statins, beta blockers, and oral anticoagulants when pharmacies close, but there are opportunities for health policy, payers, and pharmacies themselves to help.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 26, 2019 Category: Cardiology Tags: Cardiology News Source Type: news

ECG Challenge: Why Is His Pulse so Slow? ECG Challenge: Why Is His Pulse so Slow?
A man taking a beta-blocker presents with a pulse of 48 beats/min. What does his ECG show?Medscape Cardiology (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 26, 2019 Category: Cardiology Tags: Cardiology Clinical Case Source Type: news

People with heart disease at risk when pharmacies close
(University of Illinois at Chicago) New research shows that when pharmacies close, people stop taking widely used heart medications -- like statins, beta-blockers and oral anticoagulants -- that have known cardiovascular and survival benefits. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 19, 2019 Category: International Medicine & Public Health Source Type: news

Clinical toxicology of beta-blocker overdose in adults - Lauterbach M.
Beta-blocker overdose is potentially harmful due to the strong blood pressure-lowering and heart rate-lowering effect. However, conflicting data exist as to their differential toxicity, single-substance exposures, and the effect of co-exposure with additio... (Source: SafetyLit)
Source: SafetyLit - March 29, 2019 Category: International Medicine & Public Health Tags: Home and Consumer Product Safety Source Type: news

Beta Blockers (Drug Class, List of Brand and Generic Names)
Title: Beta Blockers (Drug Class, List of Brand and Generic Names)Category: MedicationsCreated: 11/24/1998 12:00:00 AMLast Editorial Review: 2/27/2019 12:00:00 AM (Source: MedicineNet Heart General)
Source: MedicineNet Heart General - February 27, 2019 Category: Cardiology Source Type: news

More Young Women Are Having Heart Attacks, Study Says. This Could Be Why
Younger women are having more heart attacks, and accounted for nearly a third of all female heart attack patients in recent years, according to a recent study. The news compounds a string of recent findings that have pointed to poorer overall health for young American women. “Women now, compared to younger women generations before them, are less healthy,” says study co-author Melissa Caughey, a cardiovascular epidemiologist and instructor at the University of North Carolina Chapel Hill School of Medicine. “It’s probably reflective of poorer health in general.” The study, which appeared in a sp...
Source: TIME: Health - February 21, 2019 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized healthytime onetime Research Source Type: news

Beta blockers: Do they cause weight gain?
Yes. Weight gain can occur as a side effect of some beta blockers, especially the older ones, such as atenolol (Tenormin) and metoprolol (Lopressor, Toprol-XL). The average weight gain is about 2.6 pounds (about 1.2 kilograms). Newer beta blockers, such as carvedilol (Coreg), don't usually cause weight gain as a side effect. Weight may rise [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - February 19, 2019 Category: Databases & Libraries Source Type: news

Alter Ego(s) in CAD: Insights From a Recently Departed Patient Alter Ego(s) in CAD: Insights From a Recently Departed Patient
This anecdotal case presentation focuses on author Philip Roth's perhaps not-so-fictional alter-ego and his experiences with CAD and the distressing side effects of beta-blocker therapy.European Heart Journal (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 30, 2019 Category: Consumer Health News Tags: Cardiology Journal Article Source Type: news

Kick Health launches telemedicine prescriptions, treatment delivery service for anxiety
The startup's service will give users access to doctors who can prescribe beta-blocker propranolol.   (Source: mobihealthnews)
Source: mobihealthnews - January 24, 2019 Category: Information Technology Source Type: news

Fish living downstream from wastewater treatment plants struggle to survive exposure to manmade contaminants, medications
(Natural News) A recent study published in the journal Environmental Science and Technology revealed that exposure to pharmaceutical contaminants and pollutants — such as birth-control medication, anti-depressants, and beta blockers — may drive fishes that live downstream from a typical sewage treatment plant to exert more effort on surviving. A team of researchers at McMaster University... (Source: NaturalNews.com)
Source: NaturalNews.com - January 20, 2019 Category: Consumer Health News Source Type: news

Medical News Today: Metoprolol tartrate vs. metoprolol succinate
Metoprolol tartrate and metoprolol succinate are different salt forms of metoprolol. Both drugs are beta-blockers that doctors prescribe to treat several cardiovascular conditions. However, despite being similar, they do have some different uses. Learn more here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 14, 2019 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

Medical News Today: All you need to know about metoprolol
Metoprolol is a beta-blocker that doctors often prescribe to treat cardiovascular issues, such as high blood pressure and angina. Different types of metoprolol have different uses. Learn more about how this drug works, when a doctor may prescribe it, and what the potential side effects can be here. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - December 18, 2018 Category: Consumer Health News Tags: Pharmacy / Pharmacist Source Type: news

PCI in Cancer; Beta-Blocker Prophylaxis; Stress Echo Predicts Cancer Deaths
(MedPage Today) -- Updates on the latest advances in cardio-oncology (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - December 10, 2018 Category: Cardiology Source Type: news

Flu jab is a lifesaver for heart failure patients
Researchers from the University of Copenhagen, led by cardiologist Dr  Daniel Modin, urge for the flu jab to become part of the standard treatment for heart failure, like beta blockers. (Source: the Mail online | Health)
Source: the Mail online | Health - December 10, 2018 Category: Consumer Health News Source Type: news

Effect of preadmission beta-blockade on mortality in multiple trauma - Eriksson M, von Oelreich E, Brattstr öm O, Eriksson J, Larsson E, Oldner A.
BACKGROUND: High levels of circulating catecholamines after multiple trauma have been associated with increased morbidity and mortality. Beta-adrenergic receptor antagonist (beta-blocker) therapy has emerged as a potential treatment option, but the effect ... (Source: SafetyLit)
Source: SafetyLit - December 6, 2018 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Resumption of Beta-Blockers After Noncardiothoracic Surgery Resumption of Beta-Blockers After Noncardiothoracic Surgery
For patients taking long-term beta-blockers, what is the optimal timing for resumption following noncardiac surgery?Anesthesiology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - November 29, 2018 Category: Consumer Health News Tags: General Surgery Journal Article Source Type: news

BioCardia Developing Comprehensive Approach to Treat Heart Failure
It can be a bit trick when trying to put BioCardia’s cell therapy for heart failure in one specific category. Is the CardiAmp Cell Therapy a diagnostic, device, or a biologic? Perhaps it’s all of the above. The San Carlos, CA-based company’s president and CEO painted a clearer picture for the technology noting that it could play a significant role when looking at heart failure treatment. “The [CardiAMP Cell Therapy System] is regulated by the agency [FDA] as a combination product via an IDE PMA device pathway,” Peter Altman, BioCardia...
Source: MDDI - November 16, 2018 Category: Medical Devices Authors: Omar Ford Tags: Cardiovascular Business Source Type: news

Another Chance for Medtronic ’s Renal Denervation Therapy
Medtronic has yet another chance to prove its renal denervation therapy can treat uncontrolled hypertension. The Dublin-based company has received FDA approval to begin a clinical trial to evaluate the Symplicity Spyral renal denervation system with patients on medication for high blood pressure. The ON MED Trial is a 2:1 randomized, sham-controlled study and will randomize up to 340 patients at 55 centers in the U.S., Japan, Europe, Australia and Canada. Patients will be followed out to three years. Primary safety endpoints will include major adverse events at one month and new renal artery stenosis at six months. The pri...
Source: MDDI - November 8, 2018 Category: Medical Devices Authors: Omar Ford Tags: Business Source Type: news

FDA approves Medtronic renal denervation trial in on-med patients
Medtronic (NYSE:MDT) said today that the FDA approved a clinical trial of its Symplicity Spyral renal denervation device in patients who already take medication for their high blood pressure. Fridley, Minn.-based Medtronic said the three-year, 340-patient Spyral HTN-On Med sham-controlled study is designed to compare treatment with the Symplicity Spyral device and a sham procedure, randomized on a 2:1 basis, after treatment with up to three anti-hypertensive medications, including diuretics, calcium channel blockers, ACE/ARB inhibitors and beta blockers. The primary safety endpoints include major adverse events a...
Source: Mass Device - November 8, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Featured Vascular Hypertension Medtronic Renal Source Type: news

In response to the letter to the editor: Beta blockers therapy in traumatic brain injury: is it the time to disclose the brain-cardiac interactions? - Ley EJ, Dhillon NK, Barmparas G.
[Abstract unavailable] Language: en... (Source: SafetyLit)
Source: SafetyLit - November 2, 2018 Category: International Medicine & Public Health Tags: Alcohol and Other Drugs Source Type: news

Adulterated Supplements; Fatty Acids and Aging: It's PodMed Double T! (with audio)
(MedPage Today) -- This week's topics also include include cardiovascular benefits from bariatric surgery and beta blockers in pregnancy (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - October 20, 2018 Category: American Health Source Type: news

Day of discharge does not influence heart surgery patient readmission rates, study finds
FINDINGSA study has found that the day of the week that a patient is discharged from the hospital does not affect the likelihood that he or she will be readmitted. The study showed comparable readmission rates for weekday and weekend or holiday discharge. It has been speculated that patients who are discharged on a weekend or holiday, when staff levels are typically lower, might be more likely to be readmitted to the hospital.The researchers found that the use before surgery of beta-blockers, a type of medication used to treat heart conditions; tobacco use; and surgical site infections were independent predictors of readmi...
Source: UCLA Newsroom: Health Sciences - October 17, 2018 Category: Universities & Medical Training Source Type: news

Beta-Blockers Carry Little Risk of Cardiac Birth Defects
(MedPage Today) -- Analysis excludes large relative, absolute risk of major malformations (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 16, 2018 Category: Cardiology Source Type: news

Hypertension medications ARE safe during pregnancy, study reveals
A new study from Brigham and Women's Hospital and Harvard Medical School has found that less than one percent of babies born to women who take beta-blockers have congenital malformations. (Source: the Mail online | Health)
Source: the Mail online | Health - October 15, 2018 Category: Consumer Health News Source Type: news

What Causes Hyperkalemia?
Discussion Potassium (K+) is an alkali metal (Group 1 of periodic table with Hydrogen, Lithium and Sodium) with an anatomic number of 19. Its chemical symbol K, comes from the medieval Latin, kalium which means potash (mainly potassium carbonate or potassium hydroxide), the substance it was first isolated from. Potassium is an important cation and it mainly resides in the intracellular fluid with only a small amount in the extracellular fluid. Potassium regulates cell volume, pH and enzyme functions. Hyperkalemia is defined as a potassium level> 5.5 mEq/L in children and> 6.0 mEq/L in newborns. Hyperkalemia incre...
Source: PediatricEducation.org - September 24, 2018 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news